Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 53304

AbstractCase ReportDiscussionConclusionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Case Series
Year : 2023 | Month : July | Volume : 17 | Issue : 7 | Page : WR01 - WR05 Full Version

Lucio Leprosy in Neglected Cases of Hansen’s Disease: A Series of Three Cases


Published: July 1, 2023 | DOI: https://doi.org/10.7860/JCDR/2023/62221.18139
Rajkumar Kannan, Parimalam Kumar, Bhackiya Shree Vijayan, B Yuvapriya

1. Professor, Department of Dermatology, Venereology and Leprosy, Rajiv Gandhi Government General Hospital, Madras Medical College, Chennai, Tamil Nadu, India. 2. Professor, Department of Dermatology, Venereology and Leprosy, Rajiv Gandhi Government General Hospital, Madras Medical College, Chennai, Tamil Nadu, India. 3. Resident, Department of Dermatology, Venereology and Leprosy, Rajiv Gandhi Government General Hospital, Madras Medical College, Chennai, Tamil Nadu, India. 4. Resident, Department of Dermatology, Venereology and Leprosy, Rajiv Gandhi Government General Hospital, Madras Medical College, Chennai, Tamil Nadu, India.

Correspondence Address :
Dr. Bhackiya Shree Vijayan,
Flat-C, Athipoo Flat, New No. 3, Thiruvalluvar Street, Metha Nagar, Chennai-60030, Tamil Nadu, India.
E-mail: bhackiya.shree96@gmail.com

Abstract

Lucio Leprosy is a rare form of Lepromatous leprosy, which normally occurs in chronic untreated patients of Hansen’s disease. Lucio Leprosy, was first reported from Mexico and henceforth commonly known as Mexican leprosy, but is now being increasingly reported sporadically across the globe. Lucio leprosy presents as slowly progressive diffuse infiltration of skin all over the body with shiny waxy thickened skin, loss of body hair including eyebrows and eyelashes, puffy hands and sensory loss due to involvement of dermal nerves. There will be thickening of upper eyelids that gives the patient a sleepy look (Melancholy look). This case series pertains to three such patients (58 year and 63 year old females and 55 year old male) of chronic lepromatous leprosy who had features suspicious of Lucio leprosy. Each case of the present series had a unique clinical presentation like diffuse infiltration of skin, total loss of eyebrows, oedema of hands, characteristic triangular ulcers with jagged borders and was posing challenge to the treating Dermatologist. Heavy colonisation of Mycobaterium leprae was observed in the endothelium of small capillaries in the superficial dermis. Involvement of these capillaries manifested as haemorrhage and infarction of the overlying epidermis. As this unusual variant of untreated chronic lepromatous leprosy leads to potentially lethal complications, which are irreversible therefore the present study has been designed to highlight the factors predisposing to Lucio leprosy and its impact on the quality of life.

Keywords

Distal tubular injury, False positive rheumatoid factor, Mexican leprosy, Vasculitis

Lucio leprosy is a pure, diffuse, non nodular form of lepromatous leprosy. It is encountered exclusively in Mexico and Central America and is quite rare in rest of the world. But recently Lucio Leprosy cases are being reported in few Asian countries also (1). Lucio Leprosy is a rare type of reaction seen in cases of diffuse lepromatous leprosy. It usually manifests as a painful purpuric spot that evolves into well defined, angulated, jagged ulcers involving limbs, but rarely involves trunk and face. Lucio phenomenon usually occurs in untreated patients of Hansen’s disease and defaulters (2).

Case Report

Case 1

A 58-year-old female, home maker, presented to the dermatology Outpatient Department (OPD) of a tertiary care centre, with complaints of multiple non healing ulcers, loss of eyebrows, diminished sensations over hands and feet since two months. Patient also complained of pain and foul smelling discharge from multiple non healing ulcers for the past 15 days. She was an undiagnosed, untreated case of Hansen’s disease. She didn’t have any other co-morbidities and was not taking any drugs.

Patient gave history of asymptomatic diffuse nodular lesions over anterior and posterior aspect of the trunk for the past one and half years [Table/Fig-1a,b]. Patient had diffuse infiltration of skin, coppery hue all over the skin surface, areas of blackish brown macular pigmentation [Table/Fig-2a,b], depressed bridge of the nose. Routine investigations revealed very low haemoglobin (8 gm%), patient was also positive for Anticardiolipin Antibody (ACL) and false positive Rheumatoid Factor (RF). Patient was subjected to thyroid profile screening and was found to be euthyroid. Patient was admitted and subjected to a slit skin smear, which was positive for Mycobacterium leprae and biopsy of the ulcer confirmed the diagnosis of vasculitic ulcer of Lucio Leprosy on HP examination with Haemtoxylin and Eosin (H&E) staining (Table/Fig 3).

Since the pretreatment haemoglobin level was low around 8 gm%, patient was started on Dapsone free Multibacillary Multidrug Therapy (MB-MDT) (Rifampicin 600 mg once a month and Clofazimine 300 mg once a month and 50 mg daily without Dapsone) as Dapsone has a potential to cause haemolytic anaemia, along with appropriate dose of systemic steroids as per World Health Organisation (WHO) guidelines (3),(4). Vasculitic lesions started healing well and patient was discharged, with the advice of regular follow-up of once in two weeks, for tapering of steroids and monitoring of disease activity. Patient was on MB-MDT without dapsone, since September 2021, with no known co-morbidities.

Patient after taking MB-MDT for six months, defaulted for three months, and stopped systemic steroids too, and came back to Dermatology OPD, with acute exacerbation and dissemination of the lesions in the form of painful multiple vasculitic ulcers of 15 days duration. On examination, multiple painful punched out ulcers of varying size over upper and lower extremities, trunk and lower back were present (Table/Fig 4)a, lesions first started as fluid filled vesicles which then ruptured to form large triangular jagged ulcers. Patient was very weak, debilitated, with a Blood Pressure (BP) record of 70/50 mmHg.

Dermatological examination revealed multiple punched out ulcers of varying sizes with erythematous edges, necrotic non viable tissue with slough, mostly present on the limbs and less on abdomen and face (Table/Fig 4)b. There was total loss of eyebrows and eyelashes with ear lobe infiltration (Buddha ear). Patient also had ulcers involving the malar area which showed the severity of Lucio phenomenon (Table/Fig 5)a,b.

Laboratory investigations revealed low haemoglobin- 5.9 gm%, serum potassium- 3.4 mmol/lit, albumin- 2.9 gm/dL, other parameters were normal. As patient had anticardiolipin, antibody positive, areas of calciphylaxis, over a period of time ulcerated to form typical vasculitic ulcers of lucio phenomenon. Patient had features of septicaemia, because of chronic malnutrition patient was debilitated, hence couldn’t even accomplish the task of day to day activities of life. Patient was started on Inj. noradrenaline drip as per physician’s opinion for a period of three days. After three days patient was started on parenteral fluids to restore normal BP and maintain her basic fluid and electrolyte balance. i.v. Antibiotics (Inj piperacillin- tazobactum 4.5 gm i.v. tds and Inj. meropenam 1 gm i.v. tds for 14 days) were started according to pus Culture and Sensitivity (C/S). Two units of Packed Red Blood Cells (PRBCs) were transfused and patient Hb improved to 8.9 gm%. As the general condition of the patient improved, in order to halt the progression of Lucio phenomenon, the patient was started on Inj. methylprednisolone pulse 250 mg and 2500 mg in 500 mL of normal saline, slow i.v., over a period of four hours, given three weeks apart, in order to improve the tolerance of the patient to supra pharmacological doses of super potent steroid. Even after Inj. methyl prednisolone was stopped and inspite of oral Potassium Chloride (KCL) two tsp tds, supplementation patient had persistent hypokalemia and hence Nephrologist opinion was sought. For correction of hypokalemia Inj. KCL two ampules, followed by two ampules of Magnesium Sulphate (MgSO4), were given for five days along with oral syp KCL 30 mL QID daily.

Inspite of all these interventions serum potassium was 3.4, and thus the Nephrologist suspected Distal Tubular Injury of the kidneys, because of long standing untreated and defaulted lepromatous leprosy, which was confirmed by, acid loading test and urine pH (>5.5) was monitored along with urine creatinine (14 mg%) and potassium level estimation which finally confirmed distal tubular injury. In a long standing case of lepromatous leprosy down grading to Lucio Leprosy, irreversible distal tubal injury, is a new finding that was encountered in this case series of Lucio Leprosy. Patient’s potassium level was stabilised at 4 meq/lit and patient was shifted to oral supplements syp. KCL, 2 tsp tds. As the patient has got irreversible distal tubular injury, Patient has to be on oral potassium supplements life long with regular monitoring of serum potassium levels. After all these interventions patient’s condition improved, ulcers started healing (Table/Fig 6)a-c. Patient was discharged after three months of inpatient care and had been advised to attend the OPD for regular follow-up.

Case 2

A 63-year-old female, a known case of lepromatous leprosy, presented at the Dermatology OPD of a tertiary care centre, with the complaint of ulcer over both legs with maggots since two weeks, patient was declared Released From Treatment (RFT) in 2018 with no known co-morbidities.

Dermatological examination revealed triangular jagged ulcers present over both lower limbs with unhealthy granulation tissue, and morphology of the ulcers were compatible with vasculitic ulcers of Lucio leprosy. Patient had diffuse infiltration of skin with total loss of eyebrows. There was a large triangular jagged out ulcer, larger in dimension in left leg than right leg. The ulcer didn’t show a tendency to heal inspite of standard treatment with both broad spectrum parenteral antibiotics along with topical human recombinant epidermal growth factor. After ensuring Blood C/S and Pus C/S negative patient was started on parenteral steroids viz., Inj dexamethasone 2 cc i.m. OD for a period of two weeks and then gradually tapered as 5 mg/wk and converted into oral steroids. Maggots were removed and she was treated with antibiotics (T.linezolid 600 mg BD for 14 days and Inj. cefoperazone sulbactum 1.5 gm i.v. BD for 14 days). Laboratory investigations revealed Anticardiolipin antibodies, IgG (> 26 GPL U/mL) and IgM (>14 GPL U/mL), Erythrocyte Sedimentation Rate (ESR), and C-Reactive Protein (CRP) were elevated. Patient was started on phenytoin dressing of ulcer over right foot and three sittings of Platelet-Rich Fibrin (PRF) dressing for ulcer over left foot was given.

Lesions were healing only partially and fresh viable epithelial tissue growth was not observed even after three sessions of PRF dressing over left foot (Table/Fig 7)a,b with all these conservative management and special intervention of Platelet-Rich Plasma (PRP) and PRF nearly for two months, the ulcers didn’t show signs of healing. Hence, the markers of acute inflammation were repeated, along with repeat ACL which still showed ACL positivity along with increased ESR, CRP.

Hence, pus c/s was repeated and patient was started on Inj. piptaz as Proteus mirabalis isolated was sensitive to the same. Patient was started on parenteral steroid, inj.dexamethasone 2 cc I.M., od for two weeks. Doses were gradually tapered and converted into oral steroids for a period of eight weeks. Lesions started healing well (Table/Fig 8)a,b, thereby justifying the diagnosis of Lucio Vasculitic ulcers. Patient was advised to come to Hansen OPD for regular follow-up, postdischarge for the purpose of tapering of steroids and to ensure complete healing of vasculitic ulcer.

Case 3

A 55-year-old male presented to the dermatology OPD with the complaint of ulcer over both lower limbs, upper limbs and ears associated with fever since 15 days. History of dark coloured skin patches which progressed to form multiple ulcers over bilateral upper and lower limbs was present, also patient had total loss of eyebrows. He also had associated glove and stocking type of anaesthesia. Patient didn’t have any other co-morbidities.

Dermatological examination revealed bilateral ciliary and superciliary madarosis, saddle nose deformity (Table/Fig 9), extensive ulcerations with necrotic slough, overlying adherent blackish crust over bilateral upper and lower limbs (Table/Fig 10)a,b and necrosis of bilateral ear helices. Resorption of digits over right hand was seen (Table/Fig 11). Peripheral nerve examination showed bilateral non tender enlargement of ulnar nerves. On investigating Slit skin smear showed 3+, biopsy from the ulcer showed features suggestive of vasculitis (Table/Fig 12). Special staining of vascular endothelial cell revealed, intracellular Mycobaterium leprae, with Fite-Faracco stain (Table/Fig 13) and diffuse macrophage granulomas loaded with Acid Fast Bacilli (AFB) and hence the diagnosis of Lucio Leprosy with Lucio’s phenomenon was confirmed. He was started on parenteral antibiotics according to pus C/S (Inj. meropenam 1 gm i.v. TDS, Inj. cefoperazone sulbactum 1.5 gm i.v. BD). Then MB-MDT with parenteral steroids (Inj. decadron 2 cc im OD for a period of two weeks were started and then gradually tapered as 5 mg/wk and converted into oral steroids. Lesions started healing well then oral steroids were stopped. Patient was advised to attend Hansen OPD for follow-up and tapering of steroids. The details of the patients of Lucio Leprosy are summarised in (Table/Fig 14),(Table/Fig 15).

Discussion

The present case series even though carried out with a small sample size of three patients, throws significant light into the dark areas of Lucio Leprosy, which is now being sporadically reported from across the Globe, outside Mexico too. Long standing patients of Lepromatous leprosy, usually downgrade and land up either with Histoid Hansen or Lucio Leprosy, wherein Tenosynovitis, spontaneous skin ulceration, localised lepromatous nodules are the other unusual manifestation of Lepromatous Leprosy (5).

All the three patients responded to daily dose of parenteral steroids (Inj. dexamethasone) along with MB-MDT. Inj. methyl prednisolone, if started after appropriate investigations like Complete blood count, fasting blood sugar, fasting lipid profile, renal and liver function test, serum electrolytes, and adequate monitoring of vitals, could be a wonderful tool in the dermatologist armamentarium to achieve quick control of disease activity. Also, add on take home message from first case of this series is that, in individuals not responding to oral or parenteral potassium supplements alone, the potential advantage of concomitant administration of parenteral magnesium, thereby, exploiting the “Potassium-Magnesium symport” pathway of potassium absorption in the ascending loop of Henley, can be accomplished.

Patient of Lucio leprosy who defaulted in taking MB-MDT, (case 1), posed a huge challenge to the treating Dermatologist as she was recording a low blood pressure of 70/50 mmHg, along with an extremely low Hb of 5 gm%, at the time of hospitalisation. Greatest task in resuscitating patient of Lucio Leprosy is the tight corner of blood dyscrasia and severe form of vasculitis, adding fuel to the fire will be the superadded bacterial infections in a patient of Lucio vasculitic ulcers, wherein they are prone for septicaemia and septic shock. This particular spectrum of Hansen’s disease is notorious for its Rheumatological manifestations in the form of arthritis and arthralgia with the fact many a times as these Lucio patients have false positive RF, land up for treatment with Rheumatologist (6). Anticardiolipin antibodies predispose them to painful vasculitic ulcers, which very much mimics Rheumatoid arthritis and there are cases on the records where Lucio Leprosy patients have been started on tab. methotrexate by Rheumatologist without much benefits. Also the Melancholy look (sleepy look) of these patients will mimic myxoedema, hence a thyroid profile work-up is necessary to rule out hypothyroidism (6).

Characteristic lesions of Calciphylaxis- Black areas of macular pigmentation (Table/Fig 1) occurs prior to the onset of frank punched out vasculitic ulcers which over a period of time enlarge to become large triangular jagged out ulcers that hardly show a tendency to heal without oral or parenteral steroids. Apart from systemic steroids along with MB-MDT, drugs such as Tumour Necrosis Factor alpha (TNF-α) inhibitors- Inj. etanercept, tab. pentoxifylline have been found to have a crucial role in the treatment of vasculitic ulcers. Tab. pentoxifylline 400 mg twice a day not only increases the self-life of RBCs by increasing membrane pliability but also antagonises the inflammatory cytokine TNF-α [7-9]. Inj. etanercept 50 mg. s.c., also has a promising role to play in the healing of vasculonecrotic ulcers and prevention of further progression of Lucio phenomenon.

Meticulous saline soaks, hydrogen peroxide debridement to remove the necrotic slough to prevent maggots and cutaneous myiasis is of paramount significance. The foot vasculitic ulcers on the dorsal aspect of both feet were recalcitrant to heal even with systemic steroids, which finally healed with Tab. colchicin 0.5 mg OD for three weeks. As these patients are relatively non ambulant for a long time due to vasculitic ulcers and debilitation, in the background of ACL positivity, it becomes mandatory to maintain these patients on prophylactic low dose Aspirin (T. Aspirin 75 mg/day) (10), as guarding against Deep vein thrombosis and hence pulmonary embolism. Many long standing untreated and treatment defaulting patients of lepromatous and Lucio leprosy patients develop involvement of kidneys in the long-term sequel of the disease. Spectrum of renal involvement can be of glomerulonephritis, nephrosclerosis, tubulointerstitial nephritis, granulomas and renal amyloidosis (11). Microcytic and hypochromic anaemia of erythropoietin deficiency can also occur (12),(13).

In individuals not responding to potassium supplements alone, the potential advantage of concomitant administration of parenteral magnesium, thereby, exploiting the “Potassium-Magnesium symport” pathway of potassium absorption in the ascending loop of Henley can be accomplished. As she had, distal tubular injury, that was irreversible in nature, patient warrants life time supplementation of potassium, as persistent hypokalemia, could predispose to cardiac arrhythmia. Urine acidification test is of huge significance in diagnosing the same.

An early diagnosis of Lepromatous leprosy, adequate health education, counselling regarding the potential hazards of defaulting treatment and high-risk of involvement of kidneys in long standing cases of Lepromatous spectrum are to be explained to the patients in detail, during the administration of first blister pack of MB-MDT. Paramount importance of concomitant steroids as per WHO Regime, along with MB-MDT, could be a practical feasible strategy to prevent many a potential irreversible complications of Lucio leprosy. Treating the patients to the point of smear negativity, customising the duration of treatment of individual patients as per bacterial load and immunity of the patient, rather than a fixed schedule of treatment is going to offer a promising strategy to prevent all the sequel of Lucio leprosy. As per recent guidelines of WHO recommendations, multibacillary patients of Hansen’s disease are to be kept under surveillance (14) for a period of nine years, from the day they are declared RFT, with a confirmation negative slit skin smear at the end of treatment (15).

Bacterial load, immunity of the patient, ability of Mycobaterium leprae, to manage gaining access into vascular endothelial cells, transepidermal elimination of Mycobaterium leprae, as documented by Ghorpade AK, secondary bacterial resistance to MB-MDT, brought about by, inadequate and irregular treatment, are crucial epidemiological factors predisposing a patient of Hansen’s disease into Lucio leprosy and hence Lucio phenomenon (16).

Conclusion

Distal tubular injury can occur in long standing cases of Lucio/lepromatous leprosy in the absence of glomerular involvement. Malar area lesions in Lucio indicate severity of the disease. Complete treatment of leprosy to the point of smear negativity or adequate treatment of Lepromatous leprosy (As per WHO recommendations 12 months within 18 months) would be a promising strategy to prevent patients of Lepromatous leprosy getting into Lucio leprosy and hence, Lucio phenomenon. Steroids will be the sheet anchor of treatment of Lucio leprosy along with MB-MDT to prevent complications like vasculitis, blood dyscrasias and renal failure.

References

1.
Choon SE, Tey KE. Lucio’s phenomenon: A report of three cases seen in Johor, Malaysia. Int J Dermatol [Internet]. 2009;48(9):984-88. [crossref][PubMed]
2.
Ya SNC, Muhamad R, Zakaria R, Ishak A, Abdullah WNHW. Lucio phenomenon: Sequelae of neglected leprosy. Korean J Fam Med. 2021;42(3):245-49. Doi: 10.4082/kjfm.19.0068. Epub 2020 Jan 23. PMID: 31968408; PMCID: PMC8164933. [crossref][PubMed]
3.
Deps P, Guerra P, Nasser S, Simon M. Hemolytic anemia in patients receiving daily dapsone for the treatment of leprosy. Lepr Rev. 2012;83(3):305-07. PMID: 23356031. [crossref][PubMed]
4.
WHO expert committee on Leprosy: Eight report(WHO technical report series; no 968). WHO expert committee on leprosy 2010 Geneva, switzerland, editor. www.who.int. Italy: World Health Organization; 2012, Pp. 17-36.
5.
Das P, Arora S, Singh GK. An unusual case of tenosynovitis in Hansen’s disease. Eur J Rheumatol. 2022. Doi: 10.5152/eurjrheum.2022.21125. [crossref][PubMed]
6.
Gao W, Chen Z, Jiang H, Shi Y, Zhang W, Wang H. Diffuse multibacillary leprosy patient with Lucio’s phenomenon and positive anticardiolipin antibody misdiagnosed as lupus erythematosus panniculitis in the People’s Republic of China. Infect Drug Resist. 2019;12:741-44. Doi: 10.2147/IDR.S202386. PMID: 31114260; PMCID: PMC6497491. [crossref][PubMed]
7.
Cogen AL, Lebas E, De Barros B, Harnisch JP, Faber WR, Lockwood DN, et al. Biologics in leprosy: A systematic review and case report. Am J Trop Med Hyg. 2020;102(5):1131-36. Doi: 10.4269/ajtmh.19-0616. PMID: 32157993; PMCID: PMC7204592. [crossref][PubMed]
8.
Sampaio EP, Moraes MO, Nery JA, Santos AR, Matos HC, Sarno EN. Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL). Clin Exp Immunol. 1998;111(2):300-08. Doi: 10.1046/j.1365- 2249.1998.00510.x. PMID: 9486396; PMCID: PMC1904921. [crossref][PubMed]
9.
Yuniati R, Firdaus Munita F, Dayana B. Difference of tumor necrosis factor levels in multibacillary leprosy between reversal reactions and non reversal reaction patients. PJMHS. 2018;12(3):1381-83.
10.
Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA. Antiphospholipid syndrome. Lancet. 2010;376(9751):1498-509. Doi: 10.1016/S0140-6736(10) 60709-X. Epub 2010 Sep 6. PMID: 20822807. [crossref][PubMed]
11.
Silva Junior GB, Daher Ede F, Pires Neto Rda J, Pereira ED, Meneses GC. Leprosy nephropathy: A review of clinical and histopathological features. Rev Inst Med Trop Sao Paulo. 2015;57(1):15-20. Doi: 10.1590/S0036-46652015000100002. PMID: 25651321; PMCID: PMC4325518. [crossref][PubMed]
12.
Sen R, Yadav SS, Singh U, Sehgal P, Dixit VB. Patterns of erythropoiesis and anaemia in leprosy. Lepr Rev. 1991;62(2):158-70. Doi: 10.5935/0305- 7518.19910019. PMID: 1870378. [crossref]
13.
Amalia H, Tabri F, Muchtar SV, Petellongi I, Sjahril R, Amin S. Hemoglobin and ferritin serum levels on leprosy patients before Multi Drug Therapy-World Health Organization (MDT-WHO) compared with healthy control group. IJSBAR [Internet]. 2017 Oct. 14 [cited 2022 Dec. 12];36(4):74-82. Available from: https:// www.gssrr.org/index.php/JournalOfBasicAndApplied/article/view/8270.
14.
Hazarika N, Gupta PK, Dhanta A, Singh A, Mohanty A, Gupta P. Renaissance of Hansen’s disease in post-elimination era in north india: A retrospective clinico-bacteriological study. Cureus. 2021;13(8):e17514. Doi: 10.7759/cureus.17514. PMID: 34603886; PMCID: PMC8476198. [crossref]
15.
Barbosa CC, Bezerra GSN, Xavier AT, de Albuquerque M de FPM, do Bonfim CV, de Medeiros ZM, et al. Systematic review of survival analysis in leprosy studies-including the following outcomes: Relapse, impairment of nerve function, reactions and physical disability. International Journal of Environmental Research and Public Health [Internet]. 2022;19(19):12155. Available from: http://dx.doi. org/10.3390/ijerph191912155. [crossref][PubMed]
16.
Ghorpade AK. Transepidermal elimination of Mycobacterium leprae in histoid leprosy: A case report suggesting possible participation of skin in leprosy transmission. Indian J Dermatol Venereol Leprol. 2011;77:59-61.[crossref][PubMed]

DOI and Others

DOI: 10.7860/JCDR/2023/62221.18139

Date of Submission: Dec 12, 2022
Date of Peer Review: Jan 17, 2023
Date of Acceptance: Apr 20, 2023
Date of Publishing: Jul 01, 2023

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. Yes

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Dec 13, 2022
• Manual Googling: Mar 10, 2023
• iThenticate Software: Apr 12, 2023 (2%)

ETYMOLOGY: Author Origin

EMENDATIONS: 7

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com